MedTrace Logo

Topical Timolol for the Treatment of Benign Vascular Periocular Lesions

NCT01250457 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2012-10-30

No results posted yet for this study

Summary

The purpose of this research is to find out if the use of topical timolol 0.5% solution applied twice daily will help to shrink rosacea lesions around the eye.

Conditions

  • Benign Vascular Periocular Lesions

Interventions

DRUG

topical Timolol

topical Timolol 0.5% solution applied twice daily

Sponsors & Collaborators

  • Loyola University

    lead OTHER

Principal Investigators

  • David Yoo, MD · Loyola University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01250457 on ClinicalTrials.gov